Osiris Therapeutics Inc
-
May 7- Osiris Therapeutics Inc:. *Product revenue during Q1 was $4.1 million, compared to $1.1 million during. Q1 2012* Q1 loss per share $0.08* Source text for Eikon* Further company coverage.
May 7- Osiris Therapeutics Inc:. *Product revenue during Q1 was $4.1 million, compared to $1.1 million during. Q1 2012* Q1 loss per share $0.08* Source text for Eikon* Further company coverage.